LobbyingRare Disease Company Coalition lobbying by quarter
Rare Disease Company Coalition's latest lobbying report covers Q2 2026, at $120K. The four quarters Q4 2025–Q3 2026 total $400K. Its first report covers Q4 2022; the issues it reports most are Pharmacy and Trade (Domestic & Foreign).
Rare Disease Company Coalition
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $400K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $60K | 1 |
| Q1 2023 | $60K | 1 |
| Q2 2023 | $60K | 1 |
| Q3 2023 | $60K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $130K | 1 |
| Q2 2024 | $130K | 1 |
| Q3 2024 | $140K | 1 |
| Q4 2024 | $160K | 1 |
| Q1 2025 | $100K | 2 |
| Q2 2025 | $120K | 2 |
| Q3 2025 | $140K | 2 |
| Q4 2025 | $120K | 2 |
| Q1 2026 | $160K | 2 |
| Q2 2026 | $120K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$1.1M · 15 reports
- Trade$204.2K · 8 reports
- Health issues$131.7K · 6 reports
- Taxation$91.7K · 5 reports
- Budget and appropriations$47.5K · 2 reports
- Science and technology$37.5K · 2 reports
- Medicare and Medicaid$20K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES21 reports
- SENATE21 reports
- Commerce, Dept of (DOC)4 reports
- Health & Human Services, Dept of (HHS)4 reports
- Executive Office of the President (EOP)3 reports
- Natl Institutes of Health (NIH)3 reports
- Food & Drug Administration (FDA)2 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
- Office of Management & Budget (OMB)1 reports
- U.S. Trade Representative (USTR)1 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| The KPM Group DC | $860K | 9 quarters |
| In-houseRare Disease Company Coalition | $470K | 6 quarters |
| Ferox Strategies | $250K | 5 quarters |
| LMH Strategic Solutions | $40K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| GABBI SALMON | Legislative Intern, Sen. Lamar Alexander. | Q1 2026 |
| CRISTINA ANTELO | Legal Fellow, Senate Democratic Steering Committee. | Q3 2025 |
| DEBRA DIXON | Chief of staff to Rep. Xavier Becerra, legislative director to Rep. Becerra, legislative counsel to Rep. Becerra, chief of staff, Office of Policy and Planning, U.S. Department of Education, Immigration Counsel, U.S. Department of Justice | Q3 2025 |
| MARK WILLIAMS | Chief of Staff, Rep. Michael Conaway // Chief of Staff, Rep. Todd Rokita // Dep. Chief of Staff/Leg. Director, Rep. Sam Johnson. | Q3 2025 |
| MICHAEL TAGGART | Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director | Q3 2025 |
| ALANNA TEMME | Legislative Director, U.S. Representative Jon Porter | Q1 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Ferox Strategies | $50K |
| 07/16for Q2 | In-house | $70K |
| 04/20for Q1 | In-house | $110K |
| 04/17for Q1 | Ferox Strategies | $50K |
| 01/20for Q4 2025 | Ferox Strategies | $50K |
| 01/20for Q4 2025 | In-house | $70K |
| 25/10/20for Q3 2025 | Ferox Strategies | $50K |
| 25/10/16for Q3 2025 | In-house | $90K |
| 25/07/18for Q2 2025 | In-house | $70K |
| 25/07/18for Q2 2025 | Ferox Strategies | $50K |
| 25/05/23for Q2 2025 | Ferox Strategies | Under $5,000 |
| 25/04/21for Q1 2025 | In-house | $60K |
| 25/04/18for Q1 2025 | In-house | Under $5,000 |
| 25/04/18for Q1 2025 | LMH Strategic Solutions | $40K |
| 25/01/21for Q4 2024 | The KPM Group DC | $160K |
| 25/01/10for Q1 2025 | LMH Strategic Solutions | Under $5,000 |
| 24/10/21for Q3 2024 | The KPM Group DC | $140K |
| 24/07/19for Q2 2024 | The KPM Group DC | $130K |
| 24/04/19for Q1 2024 | The KPM Group DC | $130K |
| 24/01/22for Q4 2023 | The KPM Group DC | $60K |